Employee Highlights
Gansu Longyao Industry Association and the U.S. Chinese Medicine Federation Chamber of Commerce, among others, have established a strategic partnership.
Release time:
2012-02-28 14:30
Xinhua Net, Gansu Channel, Lanzhou, February 23 (Reporter Wang Yanming) — To promote mutual exchange and cooperation in the field of traditional Chinese medicine, on the 23rd, the Gansu Longyao Industry Association and the U.S.-China Herbal Medicine Association, among others, established a strategic partnership.
According to the “Framework Agreement on Strategic Cooperation” signed between the Gansu Longyao Industry Association and the United States Chinese Medicine Chamber of Commerce, both parties will engage in full-chain cooperation on high-quality Longyao medicinal materials and their finished products. The Gansu Longyao Industry Association will be responsible for recommending to the member units of the United States Chinese Medicine Chamber of Commerce those Longyao products and service providers that meet international quality standards, and will also assist in selecting qualified suppliers.
In addition, both sides will also assist the government and members in carrying out exchanges and cooperation in economy, science and technology, and culture, and will leverage their respective strengths to conduct training and exchange programs for talent.
Gansu is a major province in China for the cultivation of Chinese medicinal materials. Currently, the five major categories of Chinese medicinal materials—Angelica sinensis, Codonopsis pilosula, Astragalus membranaceus (yellow and red varieties), Rheum officinale, and Glycyrrhiza uralensis—account for 90%, 60%, 50%, 50%, and 25% respectively of the nation’s total output of their respective varieties. Moreover, Gansu’s export volume of these medicinal materials exceeds 80% of the national total. Relying on its abundant resources of Chinese medicinal materials, pharmaceutical enterprises in Gansu have experienced rapid growth in recent years. At present, there are over 160 enterprises holding drug production licenses, including 17 enterprises with assets exceeding 50 million yuan. Qizheng Tibetan Medicine, Lanzhou Foci, and Duyiwei have become listed companies on China’s A-share market. To foster and strengthen the Longyao pharmaceutical industry, the Gansu Longyao Industry Association announced its establishment on the 23rd in Lanzhou.
The United States Chinese Medicine Association was established in 1984. It is a non-profit organization that brings together importers, distributors, agents, retailers, and wholesalers of Chinese medicinal products, primarily operating in Northern California. It is also one of the most influential professional Chinese-American organizations in the United States.
To promote the development of the Chinese medicinal herb industry in Gansu Province, on that day, the Gansu Longyao Industry Association also signed strategic cooperation framework agreements separately with the Taiwan Agricultural Merchants Association, the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce, and the Guangdong-Gansu Chamber of Commerce. (End)
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO